4C Medical Technologies has closed its Series D financing round, raising gross proceeds of up to $175m. Led by Boston ...

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

"We are excited to welcome Boston Scientific and thank our shareholders for their support with our financing," said Saravana Kumar, PhD, chief executive officer and president at 4C Medical.

C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...